Health
First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease
Headline as filed by Medical Xpress.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| Medical Xpress | First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease |
Mayo Clinic researchers are studying whether low-dose radiation therapy can slow the progression of Parkinson's disease by targeting inflammation in areas of the brain affected by the disease. The cli |
0m | medicalxpress.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.